KALV
KalVista Pharmaceuticals, Inc.$27.00+0.00 (—)Prev Close$26.99·MCap$1.44B·P/E—·Vol—·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
49
$7.63M
◆
Net Activity
Net Seller
$7.63M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at KalVista Pharmaceuticals, Inc. (KALV) has been exclusively selling, with 0 insider purchases totaling $0.00 and 49 insider sales totaling $7.63M. The most recent insider transaction was by Yea Christopher (officer: CHIEF DEVELOPMENT OFFICER), who sold $905.2K worth of shares on May 29, 2026. KalVista Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.44B.
KALV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 33,800 | $26.78 | $905.2K | 229,918 |
| May 27, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,966 | $26.78 | $52.6K | 229,918 |
| May 27, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,489 | $26.78 | $39.9K | 59,291 |
| May 27, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,239 | $26.78 | $60.0K | 150,260 |
| May 26, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,861 | $26.78 | $49.8K | 55,780 |
| May 26, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,685 | $26.78 | $71.9K | 147,499 |
| May 26, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 2,358 | $26.78 | $63.2K | 228,759 |
| May 26, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,489 | $26.78 | $39.9K | 21,661 |
| May 26, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,926 | $26.78 | $292.6K | 479,989 |
| May 19, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,108 | $26.76 | $29.7K | 227,367 |
| May 19, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,129 | $26.76 | $30.2K | 467,665 |
| May 19, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 1,032 | $26.76 | $27.6K | 143,934 |
| May 13, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,322 | $26.71 | $88.7K | 466,375 |
| Apr 20, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,550 | $20.22 | $193.1K | 462,577 |
| Apr 20, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,862 | $20.22 | $37.6K | 18,150 |
| Apr 20, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,862 | $20.22 | $37.6K | 51,391 |
| Apr 20, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,686 | $20.22 | $54.3K | 142,547 |
| Mar 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Sell | 214,631 | $17.20 | $3.69M | 5,129,500 |
| Mar 10, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,693 | $16.08 | $107.6K | 451,815 |
| Feb 24, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 5,354 | $15.57 | $83.3K | 138,983 |
| Feb 24, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,034 | $15.57 | $156.2K | 442,883 |
| Feb 24, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,767 | $15.57 | $27.5K | 13,762 |
| Feb 24, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 3,975 | $15.57 | $61.9K | 47,003 |
| Feb 24, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 4,347 | $15.57 | $67.7K | 226,701 |
| Feb 17, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 1,163 | $15.00 | $17.4K | 0 |
| Feb 17, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 1,038 | $15.00 | $15.6K | 0 |
| Feb 17, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 1,109 | $15.00 | $16.6K | 0 |
| Feb 13, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,354 | $15.70 | $52.7K | 428,286 |
| Dec 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $16.51 | $120.4K | 424,520 |
| Dec 4, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 3,813 | $13.45 | $51.3K | 39,728 |
| Nov 26, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 5,296 | $13.45 | $71.2K | 131,831 |
| Nov 26, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 10,940 | $13.45 | $147.2K | 416,189 |
| Nov 26, 2025 | Piekos Brian | Chief Financial Officer | Sell | 4,471 | $13.45 | $60.1K | 10,529-30% |
| Nov 26, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 4,331 | $13.45 | $58.3K | 223,508 |
| Nov 19, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 3,075 | $14.48 | $44.5K | 125,877 |
| Nov 19, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 4,466 | $14.48 | $64.7K | 403,879 |
| Nov 19, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,683 | $14.48 | $38.8K | 133,574 |
| Nov 13, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 3,328 | $11.55 | $38.4K | 398,981 |
| Sep 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $15.84 | $115.5K | 395,189 |
| Aug 26, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,336 | $13.42 | $31.3K | 122,505 |
| Aug 26, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,480 | $13.42 | $19.9K | 32,291 |
| Aug 26, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 1,954 | $13.42 | $26.2K | 132,052 |
| Aug 25, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,942 | $13.22 | $38.9K | 119,841 |
| Aug 25, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 10,940 | $13.22 | $144.7K | 386,858 |
| Aug 25, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,864 | $13.22 | $24.6K | 28,771 |
| Aug 25, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,362 | $13.22 | $31.2K | 130,881 |
| Aug 19, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,939 | $13.19 | $38.8K | 116,533 |
| Aug 19, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 4,409 | $13.19 | $58.1K | 374,548 |
| Aug 19, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,649 | $13.19 | $34.9K | 129,493 |
| Jul 10, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 32,979 | $15.69 | $517.5K | 369,595 |
Showing 1–50 of 157
1 / 4
KALV Insider Buying Activity
The following table shows recent insider purchases of KalVista Pharmaceuticals, Inc. (KALV) stock reported via SEC Form 4 filings.
No insider buying activity found for KALV in the last 12 months.
KALV Insider Selling Activity
The following table shows recent insider sales of KalVista Pharmaceuticals, Inc. (KALV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 33,800 | $26.78 | $905.2K | 229,918 |
| May 27, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,966 | $26.78 | $52.6K | 229,918 |
| May 27, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,489 | $26.78 | $39.9K | 59,291 |
| May 27, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,239 | $26.78 | $60.0K | 150,260 |
| May 26, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,861 | $26.78 | $49.8K | 55,780 |
| May 26, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,685 | $26.78 | $71.9K | 147,499 |
| May 26, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 2,358 | $26.78 | $63.2K | 228,759 |
| May 26, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,489 | $26.78 | $39.9K | 21,661 |
| May 26, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,926 | $26.78 | $292.6K | 479,989 |
| May 19, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,108 | $26.76 | $29.7K | 227,367 |
| May 19, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,129 | $26.76 | $30.2K | 467,665 |
| May 19, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 1,032 | $26.76 | $27.6K | 143,934 |
| May 13, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,322 | $26.71 | $88.7K | 466,375 |
| Apr 20, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,550 | $20.22 | $193.1K | 462,577 |
| Apr 20, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,862 | $20.22 | $37.6K | 18,150 |
| Apr 20, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 1,862 | $20.22 | $37.6K | 51,391 |
| Apr 20, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 2,686 | $20.22 | $54.3K | 142,547 |
| Mar 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Sell | 214,631 | $17.20 | $3.69M | 5,129,500 |
| Mar 10, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,693 | $16.08 | $107.6K | 451,815 |
| Feb 24, 2026 | Audhya Paul K. | officer: CHIEF MEDICAL OFFICER | Sell | 5,354 | $15.57 | $83.3K | 138,983 |
| Feb 24, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,034 | $15.57 | $156.2K | 442,883 |
| Feb 24, 2026 | Piekos Brian | officer: Chief Financial Officer | Sell | 1,767 | $15.57 | $27.5K | 13,762 |
| Feb 24, 2026 | Sweeny Nicole | officer: Chief Commercial Officer | Sell | 3,975 | $15.57 | $61.9K | 47,003 |
| Feb 24, 2026 | Yea Christopher | officer: CHIEF DEVELOPMENT OFFICER | Sell | 4,347 | $15.57 | $67.7K | 226,701 |
| Feb 17, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 1,163 | $15.00 | $17.4K | 0 |
| Feb 17, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 1,038 | $15.00 | $15.6K | 0 |
| Feb 17, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 1,109 | $15.00 | $16.6K | 0 |
| Feb 13, 2026 | Palleiko Benjamin L | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,354 | $15.70 | $52.7K | 428,286 |
| Dec 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $16.51 | $120.4K | 424,520 |
| Dec 4, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 3,813 | $13.45 | $51.3K | 39,728 |
| Nov 26, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 5,296 | $13.45 | $71.2K | 131,831 |
| Nov 26, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 10,940 | $13.45 | $147.2K | 416,189 |
| Nov 26, 2025 | Piekos Brian | Chief Financial Officer | Sell | 4,471 | $13.45 | $60.1K | 10,529-30% |
| Nov 26, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 4,331 | $13.45 | $58.3K | 223,508 |
| Nov 19, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 3,075 | $14.48 | $44.5K | 125,877 |
| Nov 19, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 4,466 | $14.48 | $64.7K | 403,879 |
| Nov 19, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,683 | $14.48 | $38.8K | 133,574 |
| Nov 13, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 3,328 | $11.55 | $38.4K | 398,981 |
| Sep 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $15.84 | $115.5K | 395,189 |
| Aug 26, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,336 | $13.42 | $31.3K | 122,505 |
| Aug 26, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,480 | $13.42 | $19.9K | 32,291 |
| Aug 26, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 1,954 | $13.42 | $26.2K | 132,052 |
| Aug 25, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,942 | $13.22 | $38.9K | 119,841 |
| Aug 25, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 10,940 | $13.22 | $144.7K | 386,858 |
| Aug 25, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | 1,864 | $13.22 | $24.6K | 28,771 |
| Aug 25, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,362 | $13.22 | $31.2K | 130,881 |
| Aug 19, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | 2,939 | $13.19 | $38.8K | 116,533 |
| Aug 19, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 4,409 | $13.19 | $58.1K | 374,548 |
| Aug 19, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | 2,649 | $13.19 | $34.9K | 129,493 |
| Jul 10, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | 32,979 | $15.69 | $517.5K | 369,595 |
KALV Insiders
Venrock Healthcare Capital Partners III, L.P.
10% Owner
Bought $19.44MSold $3.69M
14 tradesLast: Mar 27, 2026
Similar Stocks to KALV
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B